Back
NovaBay Pharmaceuticals Vs. UniFirst Industry Stock Comparison
Buy
60
NBY
NovaBay Pharmaceuticals
Last Price:
$0.72
Seasonality Move:
1.32%
Buy
64
UNF
UniFirst
Last Price:
$222.86
Seasonality Move:
1.16%
Buy
60
NovaBay Pharmaceuticals (NBY)
is a Buy
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.81. The Score for NBY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
NBY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.81The current trend is moderately bullish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
UNF Stock Price Chart
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 68.78 | Buy |
Chaikin Money Flow: | 260905 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.54 - 0.7) | Buy |
Bollinger Bands (100): | (0.53 - 0.71) | Buy |
UNF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 11.29 | Buy |
Relative Strength Index (14 RSI): | 71.53 | Buy |
Chaikin Money Flow: | 150469 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (172.04 - 218.98) | Buy |
Bollinger Bands (100): | (179.51 - 205.73) | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.72 | Buy |
20-day SMA: | 0.64 | Buy |
50-day SMA: | 0.63 | Buy |
200-day SMA: | 1.51 | Sell |
8-day EMA: | 0.72 | Buy |
20-day EMA: | 0.67 | Buy |
50-day EMA: | 0.65 | Buy |
200-day EMA: | 4 | Sell |
UNF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 226.26 | Buy |
20-day SMA: | 198.22 | Buy |
50-day SMA: | 196.86 | Buy |
200-day SMA: | 181.02 | Buy |
8-day EMA: | 221.66 | Buy |
20-day EMA: | 207.94 | Buy |
50-day EMA: | 198.31 | Buy |
200-day EMA: | 185.83 | Buy |
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.44 per share, and an increase next year of $0.44 per share.
UniFirst Earnings Growth & UNF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $1.08 per share, a decrease this year of $0.07 per share, and an increase next year of $0.81 per share.
NovaBay Pharmaceuticals Technical Analysis
Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
UniFirst Technical Analysis
Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |